Care Partner Assessment Tool for Dementia
Trial Summary
What is the purpose of this trial?
The purpose of this study is to see whether an adapted questionnaire called the Care Partner Hospital Assessment Tool (CHAT) for care partners of hospitalized patients living with Alzheimer's disease and related dementias (ADRD) (CHAT-AD) can help people with dementia receive better care after they go home from the hospital. Participants will be a care partner ('family member or friend') who provides unpaid care to a hospitalized adult relative or partner to help them take care of themselves because of dementia. Participants can expect to be in this study for 14 days.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Care Partner Hospital Assessment Tool (CHAT) for dementia?
The CHAT has been shown to be a feasible and appropriate tool for identifying the needs of care partners of hospitalized older adults, which can help tailor education and skills training to better prepare them for caregiving responsibilities. Although it has not yet been specifically tested for dementia care, its design and validation suggest it could be beneficial in this context.12345
Is the Care Partner Assessment Tool for Dementia safe for use in humans?
The Care Partner Assessment Tool, also known as CHAT, has been evaluated for its feasibility and appropriateness in hospital settings, but there is no specific safety data available for its use in humans. It is designed to help identify and address the needs of care partners, but it does not involve any direct medical treatment or intervention.12345
How does the Care Partner Assessment Tool for Dementia differ from other treatments for dementia?
The Care Partner Assessment Tool for Dementia is unique because it focuses on identifying and preparing care partners (family members or friends) of people with dementia during hospitalization, rather than directly treating the dementia itself. This tool helps ensure that care partners are equipped with the necessary skills and information to support their loved ones, which is a novel approach compared to traditional treatments that primarily target the symptoms of dementia.13456
Research Team
Beth Fields, PhD
Principal Investigator
University of Wisconsin, Madison
Eligibility Criteria
This trial is for adult care partners who provide unpaid assistance to a hospitalized relative or partner with Alzheimer's disease or related dementias (ADRD). Participants must be over 18 and speak English. It's not suitable for those who cannot communicate in English.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Adaptation and Co-design
Adaptation of CHAT-AD through co-design sessions with stakeholders
Recruitment and Randomization
Recruitment of care partners and randomization into intervention or control groups
Intervention
Participants receive either the adapted CHAT-AD intervention or standard care
Follow-up
Participants are monitored for outcomes such as care partner satisfaction and burden
Treatment Details
Interventions
- Care Partner Hospital Assessment Tool
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Institute on Aging (NIA)
Collaborator